Reuters logo
a month ago
BRIEF-Cascadian Therapeutics announces positive regulatory update for Tucatinib in Europe
July 11, 2017 / 12:14 PM / a month ago

BRIEF-Cascadian Therapeutics announces positive regulatory update for Tucatinib in Europe

July 11 (Reuters) - Cascadian Therapeutics Inc

* Cascadian Therapeutics announces positive regulatory update for tucatinib in Europe

* Cascadian Therapeutics Inc - ‍announced outcome of discussions with European Medicines Agency (EMA) regarding development of tucatinib​

* Cascadian Therapeutics - received confirmation that positive results from her2climb could serve as single registrational trial for submission of MAA to EMA, potential marketing approval​

* Cascadian Therapeutics - ‍site, patient enrollment currently ahead of schedule in n. America, Poised to begin enrolling patients in her2climb in other countries​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below